Pharmacological approach

P. M. A. Calverley (Liverpool, United Kingdom)

Source: Annual Congress 2006 - The critically ill patient: chronic obstructive lung disease

Session: The critically ill patient: chronic obstructive lung disease
Session type: Symposium
Number: 2131

Disease area: Airway diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. M. A. Calverley (Liverpool, United Kingdom). Pharmacological approach. Annual Congress 2006 - The critically ill patient: chronic obstructive lung disease

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Pharmacological management Source: Eur Respir Monogr 2016; 71: 196-217 Year: 2016
Pharmacological treatments Source: Research Seminar 2021 – Unravelling severe exacerbations of COPD – CICERO an ERS CRC Year: 2021
Pharmacological treatment Source: International Congress 2017 – Latest GOLD update Year: 2017
Pharmacological properties of a novel PI3Kd inhibitor, DS-1515 Source: International Congress 2018 – Basic pharmacology Year: 2018
Pharmacological option for hyperinflation Source: International Congress 2014 – Severe lung hyperinflation: troubles and solutions Year: 2014
Pharmacological and Non-pharmacological therapies that modulare lung function decline Source: Research Seminar 2021 – Lung function trajectories from birth to death, health and disease, and pre-war to today Year: 2021
Current opinion: Pharmacological approaches in asthma and COPD Source: Breathe 2009; 6: 24-35 Year: 2009
Pharmacological prevention of VAP Source: Annual Congress 2003 - The diagnosis and prevention of ventilator-associated pneumonia Year: 2003
Pharmacological options for the treatment of COPD: present and future Source: Annual Congress 2007 - PG6 - COPD: comprehensive clinical assessment and pharmacological and nonpharmacological therapy Year: 2007
Clinical approach Source: Virtual Congress 2021 – ERS guidelines on non-continuous positive airway pressure therapies in obstructive sleep apnoea Year: 2021
Pharmacological profile and efficacy of GLPG1690, a novel ATX inhibitor for COPD treatment Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015